tender for the procurement and supply of anti cancer drugs , afatinib tab30 mg , azathioprine tab ip50 mg , cyclophosphamide inj ip200 mg , cyclophosphamide inj ip500 mg , cyclophosphamide inj ip1 gm , cyclophosphamide tab ip50 mg , dacarbazine inj ip/usp200 mg , dactinomycin inj0.5 mg/3 ml , daunorubicin inj ip20 mg , decitabine inj50 mg , decitabine inj30 mg , dexamethasone tab ip8 mg , dexamethasone tab ip4 mg , enzalutamide cap80 mg , everolimus tab10 mg , everolimus tab5 mg , exemestane tab ip25 mg , fludarabine phosphate inj ip/ usp50 mg , flurouracil inj ip250 mg , flurouracil inj ip500 mg , ibandronate tab50 mg , ifosfamide with mesna inj1 gm , ifosfamide with mesna inj2 gm , leucovorin calcium inj ip15 mg , megestrol acetate tab ip/bp/usp40 mg , melphalan tab ip5 mg , mesna inj200 mg , methotrexateinj ip500 mg , methotrexate inj (intrathecal, preservative free)15 mg , mitomycin for inj ip/usp10 mg , mitoxantrone infusion bp/usp20 mg , nilotinib cap200 mg , nilotinib cap150 mg , pomalidomide cap2 mg , procarbazine hcl cap ip50 mg , rasburicase inj1.5 mg , regorafenib tab40 mg , rucaparib tab300 mg , tegafur +uracil cap100 mg + 224 mg , vinblastine sulphate inj ip10 mg , vincristine sulphate inj ip/usp1 mg